カテゴリー： Inkwood Research, 世界, 産業機械/建設

世界の3Dバイオプリンティング市場2023-2032

◆英語タイトル：GLOBAL 3D BIOPRINTING MARKET FORECAST 2023-2032

Inkwood Researchが発行した調査報告書（INK23JUL001）◆商品コード：INK23JUL001
◆発行会社（リサーチ会社）：Inkwood Research
◆発行日：2023年4月3日
◆ページ数：236
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：産業装置
◆販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Inkwood Research社の本調査資料では、3Dバイオプリンティングの世界市場が2023年〜2032年の間に年平均成長率16.69%を記録すると予測しています。本資料は、3Dバイオプリンティングの世界市場について調べ、調査範囲・調査手法、エグゼクティブサマリー、市場動向、主要分析、コンポーネント別（3Dバイオプリンタ、バイオインク）分析、生体材料別（ハイドロゲル、生細胞、細胞外マトリックス、その他）分析、技術別（磁気浮上型バイオプリンティング、インクジェット型バイオプリンティング、シリンジ/押出型バイオプリンティング、レーザー支援バイオプリンティング、その他）分析、用途別（医薬品試験・開発、組織エンジニアリング・再生医療、食品検査、研究、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ、アメリカ、カナダ、イギリス、ドイツ、フランス、イタリア、スペイン、中国、日本、インド、韓国、シンガポール、タイ、その他地域）分析、競争状況などの項目を掲載しています。また、3D BIOPRINTING SOLUTIONS、ADVANCED SOLUTIONS LIFE SCIENCES、ALLEVI、CELLINK、COLLPLANT BIOTECHNOLOGIES LTD、CYFUSE BIOMEDICAL KK、ENVISIONTEC ṁ INCなどの企業情報が含まれています。
・調査範囲・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・世界の3Dバイオプリンティング市場規模：コンポーネント別
- 3Dバイオプリンタの市場規模
- バイオインクの市場規模
・世界の3Dバイオプリンティング市場規模：生体材料別
- ハイドロゲルにおける市場規模
- 生細胞における市場規模
- 細胞外マトリックスにおける市場規模
- その他生体材料における市場規模
・世界の3Dバイオプリンティング市場規模：技術別
- 磁気浮上型バイオプリンティングの市場規模
- インクジェット型バイオプリンティングの市場規模
- シリンジ/押出型バイオプリンティングの市場規模
- レーザー支援バイオプリンティングの市場規模
- その他技術の市場規模
・世界の3Dバイオプリンティング市場規模：用途別
- 医薬品試験・開発における市場規模
- 組織エンジニアリング・再生医療における市場規模
- 食品検査における市場規模
- 研究における市場規模
- その他用途における市場規模
・世界の3Dバイオプリンティング市場規模：地域別
- 北米の3Dバイオプリンティング市場規模
- ヨーロッパの3Dバイオプリンティング市場規模
- アジア太平洋の3Dバイオプリンティング市場規模
- 中南米の3Dバイオプリンティング市場規模
- 中東/アフリカの3Dバイオプリンティング市場規模
- アメリカの3Dバイオプリンティング市場規模
- カナダの3Dバイオプリンティング市場規模
- イギリスの3Dバイオプリンティング市場規模
- ドイツの3Dバイオプリンティング市場規模
- フランスの3Dバイオプリンティング市場規模
- イタリアの3Dバイオプリンティング市場規模
- スペインの3Dバイオプリンティング市場規模
- 中国の3Dバイオプリンティング市場規模
- 日本の3Dバイオプリンティング市場規模
- インドの3Dバイオプリンティング市場規模
- 韓国の3Dバイオプリンティング市場規模
- シンガポールの3Dバイオプリンティング市場規模
- タイの3Dバイオプリンティング市場規模
- その他地域の3Dバイオプリンティング市場規模
・競争状況

KEY FINDINGS
The global 3D bioprinting market is predicted to record a CAGR of 16.69% during the forecast period, 2023-2032. The market growth is attributed to the high prevalence of chronic disease, the growing focus on regenerative medicine, R&D investments and technological advancements, and the increasing elderly population.

MARKET INSIGHTS
3D bioprinting is an additive manufacturing process that uses biomaterials and cells like nutrients and living cells instead of traditional plastics and metals to create artificial structures that mimic natural human tissues.
The growing elderly population is a key growth driver of the global 3D bioprinting market growth. The aging population is increasingly vulnerable to bone injuries, obesity, and osteoporosis, which further contributes to the failure of orthopedic implants. In this regard, 3D bioprinted bone can be personalized to patient-specific needs.
As per the Oncology Nursing Society, around 60% of all cancers in the US occur in the older population. Such aspects raise the need for a better understanding of the drugs required for the treatment. In addition, researchers can get a better idea about how tumors react to certain drugs through 3D bioprinting tumors. Accordingly, 3D bioprinted tumors can be used to experiment with new drugs and treatments. As a result, such factors are expected to propel growth opportunities for 3D bioprinting. However, the global 3D bioprinting market growth is restrained by a lack of skilled professionals and high costs.

REGIONAL INSIGHTS
The global 3D bioprinting market growth assessment includes the geographical evaluation of North America, Europe, Asia-Pacific, and Rest of World. North America is the largest revenue-generating region in the global market, accredited to the huge geriatric population and high prevalence of cardiovascular diseases.

COMPETITIVE INSIGHTS
Prominent market leaders are investing in merger & acquisition activities and product innovations to maintain a competitive edge in the market. Some of the leading companies in the market are Advanced Solutions Life Sciences, Cyfuse Biomedical KK, GeSiM GmbH, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. EMERGENCE OF 4D BIOPRINTING AS A SUBSTITUTE FOR 3D BIOPRINTING
2.5.2. PERSONALIZED MEDICINE LIKELY TO BOOST 3D BIOPRINTING
2.5.3. RISING INTEREST IN THE APPLICATION OF BIOPRINTING AGAINST THE SARS-COV-2 VIRUS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENTS
3.1.3. RISING FOCUS ON REGENERATIVE MEDICINE
3.1.4. HIGH PREVALENCE OF CHRONIC CONDITIONS
3.2. KEY RESTRAINTS
3.2.1. OPERATIONAL CHALLENGES DURING MANUFACTURING
3.2.2. EXORBITANT COSTS OF 3D BIOPRINTERS
3.2.3. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING IN UNITED STATES
4.4.2. GROWTH PROSPECT MAPPING IN GERMANY
4.4.3. GROWTH PROSPECT MAPPING IN CHINA
4.4.4. GROWTH PROSPECT MAPPING FOR BRAZIL
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. DESIGN & SOFTWARE PROVIDERS
4.7.2. PROTOTYPE PRODUCTION
4.7.3. DISTRIBUTION
4.7.4. END-USERS
5. MARKET BY COMPONENT
5.1. 3D BIOPRINTER
5.2. BIOINK
6. MARKET BY BIOMATERIAL
6.1. HYDROGEL
6.2. LIVING CELLS
6.3. EXTRACELLULAR MATRICES
6.4. OTHER BIOMATERIALS
7. MARKET BY TECHNOLOGY
7.1. MAGNETIC LEVITATION BIOPRINTING
7.2. INKJET-BASED BIOPRINTING
7.3. SYRINGE/EXTRUSION-BASED BIOPRINTING
7.4. LASER-ASSISTED BIOPRINTING
7.5. OTHER TECHNOLOGIES
8. MARKET BY APPLICATION
8.1. DRUG TESTING & DEVELOPMENT
8.2. TISSUE ENGINEERING & REGENERATIVE MEDICINE
8.3. FOOD TESTING
8.4. RESEARCH
8.5. OTHER APPLICATIONS
9. MARKET BY END-USER
9.1. HOSPITALS
9.2. BIOPHARMACEUTICALS COMPANIES
9.3. RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
9.4. OTHER END-USERS
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. NORTH AMERICA 3D BIOPRINTING MARKET DRIVERS
10.1.3. NORTH AMERICA 3D BIOPRINTING MARKET CHALLENGES
10.1.4. NORTH AMERICA 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
10.1.5. KEY PLAYERS IN NORTH AMERICA 3D BIOPRINTING MARKET
10.1.6. COUNTRY ANALYSIS
10.1.6.1. UNITED STATES
10.1.6.1.1. UNITED STATES 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.2. CANADA
10.1.6.2.1. CANADA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.2. EUROPE
10.2.1. MARKET SIZE & ESTIMATES
10.2.2. EUROPE 3D BIOPRINTING MARKET DRIVERS
10.2.3. EUROPE 3D BIOPRINTING MARKET CHALLENGES
10.2.4. EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
10.2.5. KEY PLAYERS IN EUROPE 3D BIOPRINTING MARKET
10.2.6. COUNTRY ANALYSIS
10.2.6.1. UNITED KINGDOM
10.2.6.1.1. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.2.6.2. GERMANY
10.2.6.2.1. GERMANY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.2.6.3. FRANCE
10.2.6.3.1. FRANCE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.2.6.4. ITALY
10.2.6.4.1. ITALY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.2.6.5. SPAIN
10.2.6.5.1. SPAIN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.2.6.6. NORDIC COUNTRIES
10.2.6.6.1. NORDIC COUNTRIES 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.2.6.7. REST OF EUROPE
10.2.6.7.1. REST OF EUROPE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3. ASIA-PACIFIC
10.3.1. MARKET SIZE & ESTIMATES
10.3.2. ASIA-PACIFIC 3D BIOPRINTING MARKET DRIVERS
10.3.3. ASIA-PACIFIC 3D BIOPRINTING MARKET CHALLENGES
10.3.4. ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
10.3.5. KEY PLAYERS IN ASIA-PACIFIC 3D BIOPRINTING MARKET
10.3.6. COUNTRY ANALYSIS
10.3.6.1. CHINA
10.3.6.1.1. CHINA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3.6.2. JAPAN
10.3.6.2.1. JAPAN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3.6.3. INDIA
10.3.6.3.1. INDIA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3.6.4. SOUTH KOREA
10.3.6.4.1. SOUTH KOREA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3.6.5. SINGAPORE
10.3.6.5.1. SINGAPORE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3.6.6. THAILAND
10.3.6.6.1. THAILAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3.6.7. AUSTRALIA & NEW ZEALAND
10.3.6.7.1. AUSTRALIA & NEW ZEALAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.3.6.8. REST OF ASIA-PACIFIC
10.3.6.8.1. REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.4. REST OF WORLD
10.4.1. MARKET SIZE & ESTIMATES
10.4.2. REST OF WORLD 3D BIOPRINTING MARKET DRIVERS
10.4.3. REST OF WORLD 3D BIOPRINTING MARKET CHALLENGES
10.4.4. KEY PLAYERS IN REST OF WORLD 3D BIOPRINTING MARKET
10.4.5. REGIONAL ANALYSIS
10.4.5.1. LATIN AMERICA
10.4.5.1.1. LATIN AMERICA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.4.5.2. MIDDLE EAST & AFRICA
10.4.5.2.1. MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.2. COMPANY PROFILES
11.2.1. 3D BIOPRINTING SOLUTIONS
11.2.1.1. COMPANY OVERVIEW
11.2.1.2. PRODUCTS LIST
11.2.2. ADVANCED SOLUTIONS LIFE SCIENCES
11.2.2.1. COMPANY OVERVIEW
11.2.2.2. PRODUCTS LIST
11.2.3. ALLEVI
11.2.3.1. COMPANY OVERVIEW
11.2.3.2. PRODUCTS LIST
11.2.4. CELLINK
11.2.4.1. COMPANY OVERVIEW
11.2.4.2. PRODUCTS LIST
11.2.4.3. STRENGTHS & CHALLENGES
11.2.5. COLLPLANT BIOTECHNOLOGIES LTD
11.2.5.1. COMPANY OVERVIEW
11.2.5.2. PRODUCTS LIST
11.2.6. CYFUSE BIOMEDICAL KK
11.2.6.1. COMPANY OVERVIEW
11.2.6.2. PRODUCTS LIST
11.2.6.3. STRENGTHS & CHALLENGES
11.2.7. ENVISIONTEC ṁ INC
11.2.7.1. COMPANY OVERVIEW
11.2.7.2. PRODUCTS LIST
11.2.7.3. STRENGTHS & CHALLENGES
11.2.8. GESIM GMBH
11.2.8.1. COMPANY OVERVIEW
11.2.8.2. PRODUCTS LIST
11.2.8.3. STRENGTHS & CHALLENGES
11.2.9. INVENTIA LIFE SCIENCE PTY LTD
11.2.9.1. COMPANY OVERVIEW
11.2.9.2. PRODUCTS LIST
11.2.10. ORGANOVO HOLDINGS INC
11.2.10.1. COMPANY OVERVIEW
11.2.10.2. PRODUCTS LIST
11.2.10.3. STRENGTHS & CHALLENGES
11.2.11. REGEMAT 3D
11.2.11.1. COMPANY OVERVIEW
11.2.11.2. PRODUCTS LIST
11.2.11.3. STRENGTHS & CHALLENGES
11.2.12. REGENHU
11.2.12.1. COMPANY OVERVIEW
11.2.12.2. PRODUCTS LIST
11.2.12.3. STRENGTHS & CHALLENGES
11.2.13. REVOTEK CO LTD
11.2.13.1. COMPANY OVERVIEW
11.2.13.2. PRODUCTS LIST
11.2.14. ROKIT HEALTHCARE INC
11.2.14.1. COMPANY OVERVIEW
11.2.14.2. PRODUCTS LIST
11.2.15. STRATASYS LTD
11.2.15.1. COMPANY OVERVIEW
11.2.15.2. PRODUCTS LIST

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – 3D BIOPRINTING
TABLE 2: COMPARATIVE SUMMARY OF 3D BIOPRINTING TECHNOLOGIES
TABLE 3: LIST OF APPROVED TISSUE-ENGINEERED MEDICAL PRODUCTS (TEMPS) USED IN VARIOUS COUNTRIES
TABLE 4: GLOBAL 3D BIOPRINTING MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL 3D BIOPRINTING MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: GLOBAL 3D BIOPRINTER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL 3D BIOPRINTER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: GLOBAL BIOINK MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL BIOINK MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: GLOBAL 3D BIOPRINTING MARKET, BY BIOMATERIAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL 3D BIOPRINTING MARKET, BY BIOMATERIAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: GLOBAL HYDROGEL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL HYDROGEL MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: GLOBAL LIVING CELLS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL LIVING CELLS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: GLOBAL EXTRACELLULAR MATRICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL EXTRACELLULAR MATRICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL OTHER BIOMATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL OTHER BIOMATERIALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 22: GLOBAL MAGNETIC LEVITATION BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL MAGNETIC LEVITATION BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 24: GLOBAL INKJET-BASED BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL INKJET-BASED BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 26: GLOBAL SYRINGE/EXTRUSION-BASED BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL SYRINGE/EXTRUSION-BASED BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 28: GLOBAL LASER-ASSISTED BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: GLOBAL LASER-ASSISTED BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 30: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 31: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 32: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 34: GLOBAL DRUG TESTING & DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 35: GLOBAL DRUG TESTING & DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 36: GLOBAL TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: GLOBAL TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 38: GLOBAL FOOD TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 39: GLOBAL FOOD TESTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 40: GLOBAL RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: GLOBAL RESEARCH MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 42: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 43: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 44: GLOBAL 3D BIOPRINTING MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 45: GLOBAL 3D BIOPRINTING MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 46: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 47: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 48: GLOBAL BIOPHARMACEUTICALS COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 49: GLOBAL BIOPHARMACEUTICALS COMPANIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 50: GLOBAL RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 51: GLOBAL RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 52: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 53: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 54: GLOBAL 3D BIOPRINTING MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 55: GLOBAL 3D BIOPRINTING MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 56: NORTH AMERICA 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 57: NORTH AMERICA 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 58: NORTH AMERICA 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
TABLE 59: KEY PLAYERS OPERATING IN NORTH AMERICA 3D BIOPRINTING MARKET
TABLE 60: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 61: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 62: EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
TABLE 63: KEY PLAYERS OPERATING IN EUROPE 3D BIOPRINTING MARKET
TABLE 64: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 65: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 66: ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
TABLE 67: KEY PLAYERS OPERATING IN ASIA-PACIFIC 3D BIOPRINTING MARKET
TABLE 68: REST OF WORLD 3D BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 69: REST OF WORLD 3D BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 70: KEY PLAYERS OPERATING IN REST OF WORLD 3D BIOPRINTING MARKET
TABLE 71: LIST OF MERGERS & ACQUISITIONS
TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 73: LIST OF PARTNERSHIPS & AGREEMENTS


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の3Dバイオプリンティング市場2023-2032(GLOBAL 3D BIOPRINTING MARKET FORECAST 2023-2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • アジア太平洋の3Dバイオプリンティング市場2023-2032
  • 世界の煙感知器市場2023-2032
  • 3Dバイオプリンティングの世界市場2022年～2029年：コンポーネント別、用途別、エンドユーザー別、地域別
  • 世界のUV（紫外線）消毒装置市場2023-2032
  • 世界の産業用ロボット市場2024-2032

    • ◆H&Iグローバルリサーチのお客様（例）◆